©2019 by Dicronis GmbH

  • White Twitter Icon
  • White LinkedIn Icon
MEET OUR TEAM
 

Patrizia graduated in Pharmaceutical Sciences (Pharm. Sc.) and Medicinal and Industrial Pharmaceutical Sciences (MIPS) at ETH Zurich. She co-developed during her Master thesis the technology behind Lymphit and was awarded with the prestigious ETH Pioneer Fellowship. Currently, she manages the company, being responsible of fundraising activities, project management and business strategy.

Patrizia Marschalkova

CEO and Co-Founder

Chairman of the Board

  • Black LinkedIn Icon

Jovan graduated in Pharmaceutical Sciences (Pharm. Sc.) and Medicinal and Industrial Pharmaceutical Sciences (MIPS) at ETH Zurich. He brings hands-on experience in the commercial translation of a pharmaceutical product, maturated during his studies while working  in a early stage biotech company. At Dicronis, he is responsible of the R&D of Lymphit and further products in the pipeline.

Jovan Jancev

CTO and Co-Founder

Member of the Board

  • Black LinkedIn Icon

Dr. Jabinet holds a Master in Medical Biology from the University of Lausanne and obtained her PhD in Neuroscience at the University of Zurich. Her solid background in life sciences, matured after almost four years researching neurological disorders, and hands-on experience working in a very dynamic and multidisciplinary project, make her the perfect candidate to support our R&D department, both on the bench and the regulatory side of Lymphit and Dic02. She currently holds the position of R&D associate and regulatory and clinical affairs coordinator.

Laura Jabinet

R&D Associate

Regulatory and Clinical

Affairs Coordinator

  • Black LinkedIn Icon

Fabrizio has more than 10 years experience in business development and in bringing cutting-edge technologies to the market. He currently holds a position as Technical Director Science & Technology at Gfk and works part-time at Dicronis as business developer.

Fabrizio Esposito

BizDev and Co-Founder